President Donald Trump signed new orders imposing 100 percent tariffs on imported drugs and 25 percent duties on metal products to force manufacturing back to the US.While trade partners like the EU and Japan face lower 15 percent rates, the United Kingdom could reach a zero percent tariff if GlaxoSmithKline commits to domestic production.The administration cited national security concerns for the move as industry groups warned that the levies would significantly increase costs for consumers.